Clinical implications of prescribing nonsteroidal anti-inflammatory drugs in oral health care-a review

被引:27
作者
Nagi, Ravleen [1 ]
Devi, B. K. Yashoda [2 ]
Rakesh, N. [2 ]
Reddy, Sujatha S. [2 ]
Patil, Deepa Jatti [3 ]
机构
[1] DJ Coll Dent Sci & Res, Dept Oral Med & Radiol, Ghaziabad, Uttar Pradesh, India
[2] MS Ramaiah Univ Appl Sci, Fac Dent Sci, Dept Oral Med & Radiol, Bangalore, Karnataka, India
[3] Swami Devi Dyal Dent Coll & Hosp, Dept Oral Med & Radiol, Panchkula, Haryana, India
来源
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY | 2015年 / 119卷 / 03期
关键词
COX-2; INHIBITORS; ASPIRIN; NSAIDS; MANAGEMENT; ROFECOXIB; CELECOXIB; THERAPY; PLACEBO; STOMACH;
D O I
10.1016/j.oooo.2014.12.002
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Nonsteroidal anti-inflammatory drugs (NSAIDs), including both the traditional nonselective NSAIDs and the selective cyclooxygenase (COX)-2 inhibitors, are widely used for their anti-inflammatory and analgesic effects. They are routinely prescribed in dental practice for the management of pain and swelling. Their use in treating acute dental pain and chronic orofacial pain, as adjuncts to the treatment of periodontal disease, and to minimize edema following surgical procedures is well documented. However, long-term utilization of nonselective NSAIDs could increase the risk of gastrointestinal symptoms, ranging from mild (e. g., dyspepsia, nausea, or vomiting) to serious gastric problems (e.g., gastric bleeding or perforation). Therefore, selective COX-2 inhibitors have been developed with fewer GI side effects but the recently identified cardiovascular adverse reactions limit their routine use in dental practice. Another major concern for oral physicians is NSAID-induced mucosal lesions and prolongation of bleeding time during invasive dental procedures. This article reviews therapeutic and analgesic uses of NSAIDs in dentistry. The various issues surrounding NSAID-induced adverse reactions and their implications in dentistry are also discussed.
引用
收藏
页码:264 / 271
页数:8
相关论文
共 58 条
[1]  
Albishri J, 2013, ANAESTH PAIN INTENSI, V17, P171
[2]   Celecoxib-induced cholestatic hepatotoxicity in a patient with cirrhosis [J].
Alegria, P ;
Lebre, L ;
Chagas, C .
ANNALS OF INTERNAL MEDICINE, 2002, 137 (01) :75-75
[3]   Selective cyclooxygenase 2 inhibitors, aspirin, and cardiovascular disease - A reappraisal [J].
Baigent, C ;
Patrono, C .
ARTHRITIS AND RHEUMATISM, 2003, 48 (01) :12-20
[4]   The effects of combined oral anticoagulant-aspirin therapy in patients undergoing tooth extractions A prospective study [J].
Bajkin, Branislav V. ;
Bajkin, Ivana A. ;
Petrovic, Bojan B. .
JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 2012, 143 (07) :771-776
[5]   CUTANEOUS REACTIONS TO NONSTEROIDAL ANTI-INFLAMMATORY DRUGS - A REVIEW [J].
BIGBY, M ;
STERN, R .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1985, 12 (05) :866-876
[6]  
Bjorkman David, 1998, American Journal of Medicine, V105, p17S, DOI 10.1016/S0002-9343(98)00276-9
[7]   Acetaminophen: Acute and chronic effects on renal function [J].
Blantz, RC .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (01) :S3-S6
[8]   IDIOSYNCRATIC LIVER TOXICITY OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS - MOLECULAR MECHANISMS AND PATHOLOGY [J].
BOELSTERLI, UA ;
ZIMMERMAN, HJ ;
KRETZROMMEL, A .
CRITICAL REVIEWS IN TOXICOLOGY, 1995, 25 (03) :207-235
[9]   Mechanism of action of acetaminophen: Is there a cyclooxygenase 3? [J].
Botting, RM .
CLINICAL INFECTIOUS DISEASES, 2000, 31 :S202-S210
[10]   Aspirin and bleeding in dentistry: an update and recommendations [J].
Brennan, Michael T. ;
Wynn, Richard L. ;
Miller, Craig S. ;
Baltimore, Charlotte Nc .
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2007, 104 (03) :316-323